Literature DB >> 24584635

Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts.

Francesca Rossi1, Marco Battaglini, Maria Laura Stromillo, Antonio Giorgio, Antonio Federico, Nicola De Stefano.   

Abstract

Megalencephalic leukoencephalopathy (MLC) with subcortical cysts is an infantile-onset inherited disease of the brain white matter with a defect in brain ion and water homoeostasis, which leads to an abnormal brain volume regulation. Clinical features of the disease can be variable, but patients typically show early-onset macrocephaly, motor abnormalities, seizures, and almost constant late-onset mild mental deterioration. Brain magnetic resonance imaging (MRI) reveals diffusely abnormal and mildly swollen white matter as well as subcortical cysts in the anterior temporal and frontoparietal regions. We describe here clinical findings and volumetric MRI and (1)H-MR spectroscopic imaging ((1)H-MRSI) data of a 12-year follow-up on a patient with MLC. The patient had only slight clinical worsening during the long follow-up. Volumetric findings showed substantially unchanged cystic volumes and mild brain atrophy rate. In addition, there was no over time increase in the volume of white matter hypointense lesions seen on FLAIR images at baseline, but the degree of hypointensity of these white matter voxels increased over 12 years. Longitudinal (1)H-MRSI examination showed long-term undetectable metabolite signals in the white matter, whereas the metabolic pattern of gray matter voxels remained unchanged over time. Results show that, in MLC, the chronic brain white matter changes resulting from the brain ion, and water homeostasis can be monitored by quantitative MRI modalities. This might be important for assessing treatment effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24584635     DOI: 10.1007/s10072-014-1691-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

1.  Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients.

Authors:  B Ben-Zeev; V Gross; T Kushnir; R Shalev; C Hoffman; Y Shinar; E Pras; N Brand
Journal:  J Child Neurol       Date:  2001-02       Impact factor: 1.987

Review 2.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

3.  Severe metabolic abnormalities in the white matter of patients with vacuolating megalencephalic leukoencephalopathy with subcortical cysts. A proton MR spectroscopic imaging study.

Authors:  N De Stefano; P Balestri; M T Dotti; S Grosso; M Mortilla; G Morgese; A Federico
Journal:  J Neurol       Date:  2001-05       Impact factor: 4.849

4.  Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.

Authors:  N De Stefano; S Narayanan; G S Francis; R Arnaoutelis; M C Tartaglia; J P Antel; P M Matthews; D L Arnold
Journal:  Arch Neurol       Date:  2001-01

5.  Genetic heterogeneity of megalencephalic leukoencephalopathy and subcortical cysts.

Authors:  C Patrono; G Di Giacinto; E Eymard-Pierre; F M Santorelli; D Rodriguez; N De Stefano; A Federico; R Gatti; V Benigno; A Megarbané; B Tabarki; O Boespflug-Tanguy; E Bertini
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

Review 6.  Megalencephalic leukoencephalopathy with subcortical cysts: chronic white matter oedema due to a defect in brain ion and water homoeostasis.

Authors:  Marjo S van der Knaap; Ilja Boor; Raúl Estévez
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

7.  Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children.

Authors:  M S van der Knaap; P G Barth; H Stroink; O van Nieuwenhuizen; W F Arts; F Hoogenraad; J Valk
Journal:  Ann Neurol       Date:  1995-03       Impact factor: 10.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.